Market Overview:
The global eplerenone market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of heart failure and hypertension, increasing awareness about the benefits of eplerenone therapy, and growing demand for generic drugs. By type, the 25 mg segment is expected to account for a major share of the global market in 2018. By application, heart failure is expected to be the largest segment in 2018. Geographically, North America is estimated to dominate the global market in 2018.
Product Definition:
Eplerenone is a mineralocorticoid receptor antagonist that is used to treat hypertension, congestive heart failure, and nephrotic syndrome. By blocking the effects of aldosterone, eplerenone can help to lower blood pressure and improve heart function.
25 mg:
Eplerenone is a type of drug that is used to treat pulmonary arterial hypertension in patients. It works by increasing the blood flow through the lungs and maintaining normal functioning of the heart. The medicine has no age restrictions and can be taken by any patient irrespective of their age.
The global eplerenone market size was valued at USD 5,700 million in 2016.
50 mg:
Eplerenone is used to treat severe heart failure and pulmonary hypertension in patients with cardiomyopathy or other heart diseases. It works by improving the ability of the body to pump blood around the circuits by increasing contractility of cardiac muscles.
50 mg tablet contains a single dose of eplerenone and is available as a generic medicine.
Application Insights:
The global eplerenone market is segmented by application into heart failure, hypertension and others. Heart failure was the largest revenue-generating segment in 2017 owing to the high prevalence of cardiomyopathy which requires a daily Eplerenone dose for management. In addition, growing awareness about the benefits of eplerenone in treating patients with mild to moderate heart failure as well as improving their overall health is expected to drive demand over the forecast period.
Hypertension is anticipated to be one of fastest-growing segments during the forecast period due largely to increasing number of anti-hypertensive drugs being developed and prescribed globally on an outpatient basis owing largely due its ability reduce blood pressure without causing any kind adverse effects on cardiovascular system or other organs such as kidney or liver damage.
Regional Analysis:
Europe dominated the global eplerenone market in terms of revenue with a share of 33.0% in 2017. This is attributed to growing consumer awareness regarding health and well-being, increasing geriatric population, rising obesity rates, and high prevalence of cardiovascular diseases (CVDs) among others. In addition, presence of key manufacturers such as Merck KGaA Darmstadt GmbH & Co., Ltd.; Pfizer; Novartis AG; Sanofi; Bayer AG will also have a positive impact on the growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rise in disposable income coupled with improving healthcare infrastructure which would lead to an increase adoption rate for pharmaceutical products especially those pertaining to CVD management along with other associated conditions such as hypertension.
Growth Factors:
- Increasing incidence of hypertension and heart failure across the globe
- Rising geriatric population susceptible to heart failure
- Growing demand for novel therapeutics for the treatment of hypertension and heart failure
- Technological advancements in eplerenone drug delivery systems
- increasing healthcare expenditure by governments and private players
Scope Of The Report
Report Attributes
Report Details
Report Title
Eplerenone Market Research Report
By Type
25 mg, 50 mg
By Application
Heart failure, Hypertension
By Companies
Pfizer, Glenmark, APOTEX, Sandoz, Mylan, Accord Healthcare, Unichem, RPG Life Sciences, HBS Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Eplerenone Market Report Segments:
The global Eplerenone market is segmented on the basis of:
Types
25 mg, 50 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart failure, Hypertension
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Glenmark
- APOTEX
- Sandoz
- Mylan
- Accord Healthcare
- Unichem
- RPG Life Sciences
- HBS Healthcare
Highlights of The Eplerenone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 25 mg
- 50 mg
- By Application:
- Heart failure
- Hypertension
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eplerenone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eplerenone is a medication used to treat heart failure. It works by improving the function of the heart muscle.
Some of the major players in the eplerenone market are Pfizer, Glenmark, APOTEX, Sandoz, Mylan, Accord Healthcare, Unichem, RPG Life Sciences, HBS Healthcare.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eplerenone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eplerenone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eplerenone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eplerenone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eplerenone Market Size & Forecast, 2020-2028
4.5.1 Eplerenone Market Size and Y-o-Y Growth
4.5.2 Eplerenone Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 25 mg
5.2.2 50 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Heart failure
6.2.2 Hypertension
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eplerenone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eplerenone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 25 mg
9.6.2 50 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Heart failure
9.10.2 Hypertension
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 25 mg
10.6.2 50 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Heart failure
10.10.2 Hypertension
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 25 mg
11.6.2 50 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Heart failure
11.10.2 Hypertension
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 25 mg
12.6.2 50 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Heart failure
12.10.2 Hypertension
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 25 mg
13.6.2 50 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Heart failure
13.10.2 Hypertension
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eplerenone Market: Competitive Dashboard
14.2 Global Eplerenone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Glenmark
14.3.3 APOTEX
14.3.4 Sandoz
14.3.5 Mylan
14.3.6 Accord Healthcare
14.3.7 Unichem
14.3.8 RPG Life Sciences
14.3.9 HBS Healthcare
